Related Experiment Video
Updated: Jan 9, 2026

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
Published on: January 28, 2021
Lipoprotein (a) as an independent risk factor for myocardial infarction in patients with common hypercholesterolaemia
G F Watts1, E M Kearney, N A Taub
1Department of Endocrinology and Chemical Pathology (UMDS), St Thomas's Hospital, London.
Insights
Elevated lipoprotein (a) (Lp(a)) levels significantly increase myocardial infarction (MI) risk in men with hypercholesterolaemia. Routine Lp(a) measurement is recommended for patients at lipid clinics.
Area of Science:
- Cardiology
- Lipidology
- Preventive Medicine
Background:
- Hypercholesterolaemia is a known risk factor for myocardial infarction (MI).
- The role of lipoprotein (a) (Lp(a)) as an independent risk factor in this population requires further investigation.
Purpose of the Study:
- To determine if elevated lipoprotein (a) (Lp(a)) levels are associated with an increased risk of myocardial infarction (MI) in middle-aged men with common hypercholesterolaemia.
Main Methods:
- A case-control study comparing 15 middle-aged men with hypercholesterolaemia and a history of MI to a control group without MI.
- Measurement of serum lipids, including low-density lipoprotein (LDL) cholesterol, and lipoprotein (a) (Lp(a)) using immunoturbidity.
Main Results:
- Patients with MI had significantly higher serum Lp(a) concentrations compared to controls.
- Lp(a) was identified as the sole significant predictor of MI in logistic regression analysis.
- An Lp(a) level > 0.57 g/l was associated with an odds ratio of 16.5 for MI.
Conclusions:
- Serum Lp(a) concentration is a potent and independent risk factor for myocardial infarction in middle-aged men with common hypercholesterolaemia.
- Routine measurement of Lp(a) is suggested for all patients referred to lipid clinics.
Aims:
To examine whether lipoprotein (a) (Lp(a)) increases the risk of myocardial infarction (MI) in patients with common hypercholesterolaemia.
Methods:
15 middle aged men with common hypercholesterolaemia (mean serum low density lipoprotein (LDL) cholesterol 4.94 mmol/l, SD 1.0) and a history of MI were selected consecutively from referrals to a lipid clinic. A control group that had not sustained an MI and with similar age, sex, cigarette smoking and blood pressure characteristics was also selected from the same clinic. Serum cholesterol, triglyceride, LDL cholesterol, high density lipoprotein cholesterol, apolipoproteins AI and B and Lp(a) were measured in both groups. Lp(a) was assayed by immunoturbidity.
Results:
The serum concentration of Lp(a) was significantly higher in patients with MI (geometric mean 0.64 (95% confidence interval 0.36 to 1.14) v 0.30 (0.21 to 0.42) g/l, p = 0.02), but there were no significant differences in other variables. Stepwise logistic regression analysis showed that Lp(a) was the only significant predictor of MI (p < 0.02). The odds ratio of MI (adjusted for age, smoking, blood pressure and apolipoprotein B) for an Lp(a) of > 0.57 g/l was 16.5, 95% confidence interval 2.3 to 125.4 (p = 0.001).
Conclusion:
In middle aged men with common hypercholesterolaemia the serum concentration of Lp(a) is a powerful and independent risk factor for MI. Lp(a) should probably be routinely measured in all patients referred to a lipid clinic.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Coronary Artery Disease IV: Preventive Measures
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation
Considering cholesterol and...

